Conference · Brussels, Belgium
EORTC-NCI-ASCO Annual Meeting on Molecular Markers in Cancer 2011
Health
Key numbers
- Editions on record
- 4first in 2009
About EORTC-NCI-ASCO Annual Meeting on Molecular Markers in Cancer
The 5th EORTC - NCI - ASCO Annual Meeting on Molecular Markers in Cancer in Brussels from October 27-29, 2011.
This year’s program will focus on challenges in biomarker development for clinical application in the age of multiplex testing and genome-wide screening, as well as on molecular imaging and on drug resistance. Emerging pathways for targeted therapeutics of novel molecular entities will also be highlighted.
Biomarkers now play a key role in the routine management of patients with cancer and guide drug development in the age of targeted therapy. The meeting will aim to stimulate dialogue between all stakeholders in the field of biomarker development and utilization including clinicians, laboratory scientists, pathologists, statisticians, industry representatives, healthcare providers, regulatory agencies, and patient advocates. The program allows for interaction and discussion with an outstanding faculty.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2012 | 11–13 Oct 2012 | Westin Diplomat Resort & Spa Hollywood, Florida | — | — |
| 2011 | 27–29 Oct 2011 | Square Brussels Meeting Centre Brussels, Belgium | — | — |
| 2010 | 15 Oct 2010 | Brussels Expo Brussels, Belgium | — | — |
| 2009 | 15–17 Oct 2009 | Brussels Expo Brussels, Belgium | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.